Role of autologous haematopoietic cell transplantation in the treatment of systemic light chain amyloidosis in the era of anti-CD38 monoclonal antibodies

Chakraborty, R., Milani, P., Palladini, G., & Gertz, M. (2023). Role of autologous haematopoietic cell transplantation in the treatment of systemic light chain amyloidosis in the era of anti-CD38 monoclonal antibodies. The Lancet Haematology, 10(11), e936–e940. https://doi.org/10.1016/s2352-3026(23)00175-8
Authors:
Rajshekhar Chakraborty
Paolo Milani
Giovanni Palladini
Morie Gertz
Affiliated Authors:
Rajshekhar Chakraborty
Columbia Affiliation:
Subjects:
Antineoplastic Agents (MeSH)
Immunoglobulin Light-chain Amyloidosis (MeSH)
Amyloidosis (MeSH)
Hematopoietic Stem Cell Transplantation (MeSH)
elink
Publication Type:
Article
Unique ID:
10.1016/s2352-3026(23)00175-8
PMID:
37802087
DOI:
10.1016/s2352-3026(23)00175-8
Journal:
Lancet Haematology
Publication Date:
Data Source:
PubMed
Source Link:
View PubMed Record

Record Created: